Glial cells of the oligodendrocyte lineage express several highly related POU proteins including Tst-1/Oct6/ SCIP and Brn-1. Tst-1/Oct6/SCIP, but not Brn-1 efficiently cooperated with Sox10, the only SRY box protein so far identified in oligodendrocytes. Here we show that, in addition to Sox10, cells of the oligodendrocyte lineage contain significant amounts of the related SRY box proteins Sox4 and Sox11. During development, Sox11 was strongly expressed in the central nervous system. It was first detected in neural precursors throughout the neuroepithelium. During later stages of neural development, Sox11 was additionally expressed in areas of the brain in which neurons undergo differentiation. In agreement with its expression in neural precursors, Sox11 levels in cells of the oligodendrocyte lineage were high in precursors and down-regulated during terminal differentiation. Outside the nervous system, expression of Sox11 was also detected in the developing limbs, face, and kidneys. Structure function analysis revealed that Sox11 has a strong intrinsic transactivation capacity which is mediated by a transactivation domain in its carboxyl-terminal part. In addition, Sox11 efficiently synergized with Brn-1. Synergy was dependent on binding of both proteins to adjacent DNA elements, and required the presence of the respective transactivation domain in each protein. Our data suggest the existence of a specific code in which POU proteins require specific Sox proteins to exhibit cooperative effects in glial cells.
proteins Pit-1, Oct-1, and Oct-2 as well as in the Caenorhabditis elegans developmental regulator unc-86 (4). In the meantime, 40 different POU proteins have been identified in species ranging from nematodes to mammals (2) . These proteins can be grouped in at least 6 subclasses, with members of classes III and IV being predominantly expressed in the developing and adult nervous system (5) .
Sox proteins on the other hand bind to DNA mainly through minor groove contacts with a domain that was originally identified in the high-mobility group proteins HMG-1 and HMG-2 (6) . Contrary to the HMG box of these two chromatin proteins, the subtype of HMG domain present in all Sox proteins, the so called Sry-box (ϭ Sox), mediates sequence-specific DNA binding (7) as evidenced by the analysis of the prototypic HMG domain from the sex determining factor, SRY (8) . Similar to POU proteins, more than 20 different members of the family of Sox proteins have been characterized which can be divided into 6 different groups (1) . Expression of most Sox proteins is widespread and often includes parts of the developing or adult nervous system. Thus, most cells would be expected to express at least one member of the Sox protein family and one member of the POU family.
Members of both families have been shown to be capable of functional interaction in at least two cases. In embryonic stem cells, Oct-3/4 and Sox2 were shown to be involved in the activation of the FGF-4 gene and to functionally interact on the enhancer of this gene (9, 10) . A comparable synergistic activation of gene expression was also observed for the class III POU protein Tst-1/Oct6/SCIP and the Sox10 protein which are coexpressed in various groups of glial cells (11) .
Whereas glial cells of the Schwann cell lineage express Tst-1/Oct6/SCIP as their sole class III POU protein (12, 13) , other glial cells, for instance those of the oligodendrocyte lineage, express additional class III POU proteins (14) such as Brn-1 and Brn-2 (15). Our previous analysis had shown that contrary to Tst-1/Oct6/SCIP, Brn-1 could not functionally interact with Sox10 (11) . This observation prompted us to search for other Sox proteins in cells of the oligodendrocyte lineage and analyze them for their ability to function synergistically with Brn-1.
Here we identify the class C proteins Sox4 and Sox11 in cells of the oligodendrocyte lineage, analyze the expression of Sox11 during mouse development, and for the first time characterize its functional properties. The ability of both Sox11 and Sox4 to cooperatively function with Brn-1 leads us to postulate that there exists a specific code in which Sox proteins and POU proteins combine to exhibit synergistic properties.
EXPERIMENTAL PROCEDURES
Tissue Culture-Oligodendroglial cultures were prepared from the brains of 1-day-old Wistar rats as described (16) with minor modifications (17) . Schwann cells were isolated from 3-day-old rats by the method of Brockes et al. (18) , as modified by Porter et al. (19) . Rat CG-4 cells were grown on poly-L-ornithine-coated plates in Dulbecco's modi-fied Eagle's medium, containing N1 supplement (5 g/ml transferrin, 16 g/ml putrescine, 60 ng/ml progesterone, 50 ng/ml selenium, 5 g/ml insulin), 10 ng/ml platelet-derived growth factor, and 5 ng/ml basic fibroblast growth factor (20) . Differentiation of CG-4 cells was induced by omitting platelet-derived growth factor and basic fibroblast growth factor from the medium. U138 human glioblastoma cells were propagated in RPMI 1640 medium supplemented with 10% fetal calf serum. COS cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum.
Preparation of RNA and Reverse Transcriptase-PCR Analysis-RNA was isolated from cell cultures using Trizol reagent (Life Technologies, Inc.). Poly(A) ϩ RNA was prepared using Oligotex-dT (Quiagen). For the identification of Sox genes in oligodendroglial cells, 2 g of total RNA from CG-4 cells were reverse transcribed using Moloney murine leukemia virus reverse transcriptase and oligo(dT) primer (11) . 2 l of this reaction were amplified using the degenerate primers 5Ј-AAGGCCG-GATCCATGAA(CT)GC(ACT)TT(CT)AT(AGT)GT(TGCA)TGG-3Ј and 5Ј-AAGGCCGGATCC(TGCA)GGTCTT(AG)TA(CT)TT(AG)TA(AG)TC-(TGCA)G-3Ј as described (11) . Amplification products were subcloned into the BamHI site of pBluescript KSϩ (Stratagene) and sequenced.
For the analysis of Sox11 expression in glial cells, 2 l of cDNA from Schwann cells, CG-4 cells, and primary oligodendrocytes were amplified with primer pairs specific for rat Sox11 (5Ј-CGTTGGAAGATGCT-GAAGGACA-3Ј and 5Ј-CCGCTGGATGAGGAGGTGGACA-3Ј, yielding a 650-base pair product), Brn-1 (5Ј-CAACAGCCACGACCCTCACT-3Ј and 5Ј-CAGAACCAGACCCGCACGAC-3Ј, yielding a 450-base pair product), and GAPDH (5Ј-GCCATCAA(C/T)GACCCCTTCATT-3Јand 5Ј-CGCCTGCTTCACCACCTTCTT-3Ј, yielding a 700-base pair product). In addition to 40 pmol of each primer in a selected pair, polymerase chain reactions contained 0.2 mM dNTP, 2 nM [␣-
32 P]dCTP, and 1 unit of Taq DNA polymerase in 40 l of 10 mM Tris-HCl, pH 8.3, 10% dimethyl sulfoxide (v/v), 50 mM KCl, and 2 mM MgCl 2 . After denaturation (1 min at 94°C), 12, 15, 18, or 21 cycles were performed with each cycle consisting of a denaturation (30 s at 94°C), an annealing (30 s at 50°C), and an elongation step (45 s at 72°C). Amplification products were analyzed by autoradiography after electrophoresis on 4% polyacrylamide gels.
Library Screening and Plasmids-The 200-bp fragments corresponding to the HMG domain of Sox4 and Sox11 were radiolabeled and used to screen an oligo(dT)-primed cDNA library constructed from poly(A) ϩ RNA of undifferentiated CG-4 cells in -Ziplox (Life Technologies, Inc.). Plasmids were excised from several independent positive phages according to the manufacturer's instructions. The plasmids with the longest inserts were chosen for further analysis. Both pZL1/Sox4 and pZL1/Sox11 had 2-kilobase pair inserts, and contained the full open reading frame of either Sox protein. The sequence of rat Sox11 was determined over the open reading frame and deposited in EMBL/GenBank under accession number AJ004858. The Sox4 and Sox11 cDNA were inserted into the EcoRI site of pCMV5, yielding the mammalian expression plasmids pCMV/Sox4 and pCMV/Sox11. By adding a eukaryotic translation initiation consensus immediately in front of the HMG domain of Sox11 and by introducing a stop codon immediately behind the HMG domain of Sox11, deletion mutants Sox11⌬N and Sox11⌬C were generated in the context of pCMV5. The HMG domain of Sox11 was also inserted into pGEX-KG after PCR-directed introduction of flanking BamHI and XhoI sites. Bacterial expression of Sox11 holoprotein required the cloning of Sox11 coding sequences between EcoRI and XhoI sites of pET28 (Novagen).
Eukaryotic expression plasmids pCMV/Tst-1, pCMV/Brn-2, and pCMV/Brn-3 have been described (21) (22) (23) . pCMV/Brn-1 contained the open reading frame of rat Brn-1 as part of a 2.2-kilobase pair EcoRI, NsiI fragment. Expression plasmids for mutant Brn-1 proteins were created by deleting the region between amino acids 3 and 310 to obtain pCMV/Brn-1⌬N, by introducing a stop codon after amino acid 462 to obtain pCMV/Brn-1 ⌬C, or by changing amino acids 450 and 451 from tryptophan and phenylalanine to cysteine and serine to obtain pCMV/ Brn-1 mt.
pCMVGal4 contained coding sequences for the DNA-binding domain of the yeast Gal4 protein (24) . Insertion of Sox11 sequences led to an in-frame fusion of both open reading frames, with Sox11 following Gal4 sequences (pCMVGal4/Sox11). Fragments corresponding to amino acids 1-43, 125-395, 125-279, and 273-395 of Sox11 were generated by PCR with flanking EcoRI and KpnI sites and inserted into pCMVGal4, yielding pCMVGal4/Sox11 N, pCMVGal4/Sox11 C1, pCMVGal4/Sox11 C2, and pCMVGal4/Sox11 C3, respectively. The luciferase reporter plasmids 3xUAS luc, 3xSX luc, and 3xFXO luc have been described (11, 24) .
Northern Blot Analysis and in Situ Hybridization Histochemistry-RNA blot analysis with 4 g of poly(A) ϩ RNA and in situ hybridization on embryos from natural matings between inbred CD-1 mice were performed as described (11) . A 1.5-kilobase pair BglII/SalI fragment from pZL/Sox11, that lacked most of the sequences coding for the HMG domain of Sox11, served as a probe for Northern blot analysis after random 32 P labeling. For in situ hybridization, a 1-kilobase pair segment of the Sox11 cDNA lacking HMG domain sequences was transcribed into an antisense riboprobe by SP6 RNA polymerase after linearizing pZL1/Sox11 with StyI. For the sense probe, pZL1/Sox11 was transcribed by T7 RNA polymerase after BamHI linearization. Transcription reactions were performed using the Ambion transcription kit for the production of 35 S-UTP-labeled probes, and the Boehringer digoxigenin labeling kit for the production of digoxigenin-labeled probes.
Transfections and Luciferase Assays-U138 cells were transfected by the calcium phosphate technique as described (25) . COS cells were transfected by the DEAE dextran technique using a concentration of 500 g/ml DEAE dextran followed by chloroquine treatment (26) . For luciferase assays, cells were transfected with 2 g of luciferase reporter plasmid and 0.05-2 g of CMV expression plasmid per 60-mm plate. The total amount of plasmid was kept constant using empty CMV vector. Cells were harvested 48 h after transfection, and extracts were assayed for luciferase activity (23) .
Preparation of Recombinant Proteins and Antisera-Full-length Sox11 protein was produced in Escherichia coli BL21 DE3 as a hexahistidine fusion protein using the pET expression system (Novagen). Purified denatured Sox11 holoprotein was used as antigen to raise an antiserum in rabbit. Expression of a fusion protein between GST and the HMG domain of Sox11 from pGEX/Sox11 in E. coli DH5␣ and purification procedures were as described (25) .
Protein Extracts, Western Blots, and Electrophoretic Mobility Shift Assay-Nuclear and whole cell extracts were prepared and used for Western blots and electrophoretic mobility shift assays (11, 26) . The FXO oligonucleotide and its mutant versions FX-, F-O, and F-(sequences as shown in Fig. 6 ) were used as probes in electrophoretic mobility shift assays. 1:3000 dilutions of rabbit antisera against Sox11 or Brn-1 (15) or a mouse monoclonal against the DNA-binding domain of Gal4 (CLONTECH) served as primary antibodies in Western blots.
RESULTS
To identify Sox proteins present in oligodendroglial cells, we used the same PCR strategy which we had previously employed to identify Sox proteins in Schwann cells (11) . The degenerate primers recognized all known Sox genes equally well as evident from sequence comparison of primers and published Sox genes. The CG-4 cell line (20) served as a source for oligodendroglial cDNA. As already observed in Schwann cells, Sox10 was the most frequently detected Sox protein representing 44% of all clones. However, contrary to Schwann cells two other Sox proteins were detected in significant amounts in cDNA from CG-4 cells. Among the 25 sequenced PCR products 11 were identical to Sox4 or the related Sox11. These two Sox proteins thus also account for a combined share of 44%. No other Sox protein was detected in more than a single PCR product.
We used the PCR products corresponding to the HMG domain of Sox4 and Sox11 to screen a rat CG-4 cDNA library. The largest of the positive isolates for Sox4 and Sox11 contained the respective complete open reading frame. Whereas Sox4 has been studied extensively in the past primarily with regard to its function in lymphocytes and in the developing embryonic heart (27, 28) , comparatively little was known about Sox11 at the time. Fig. 1 shows the amino acid sequence of rat Sox11.
Comparison of the 395-amino acid open reading frame with its mouse, human, chick, and Xenopus orthologues (29 -32) revealed significant identity on the amino acid level. Homology was highest between rat and mouse with only nine amino acid differences and an overall identity of 98%. Interestingly, the rat, mouse, and chicken proteins were significantly shorter than the human protein due to the insertion of amino acid sequences in the human sequence. These insertions were primarily found in the central portion of the protein, and were largely absent from both the amino-terminal part of the protein, including the HMG domain and the carboxyl-terminal part. A similar observation was made for human and mouse Sox4 (28) .
To assess Sox11 expression in rodents, we performed in situ hybridization histochemistry on whole mounts and frozen sections of mouse embryos. At embryonic day 7.5 (E7.5), weak hybridization signals were detected over the whole embryo (data not shown). By E8.5, signal intensity had increased. Sox11-specific hybridization signals were still detected over the whole embryo with the exception of the heart primordium, and were most prominent in the neuroepithelium of the rostral neural plate and over the somites ( Fig. 2A) . At E9.5, Sox11 was also expressed in the caudal parts of the neural tube with uniform distribution of Sox11 transcripts throughout the neuroepithelium (data not shown). Strong hybridization signals were additionally detected in the optic and the otic vesicles as well as the first and the second branchial arches (Fig. 2B) . By E10.5, the central nervous system had become the main site of Sox11 expression. All compartments of the brain and spinal cord were marked (Fig. 2C ). Up to E13.5, the intensity of the hybridization signal increased without a significant change in the pattern of Sox11 expression (Fig. 2, C-E) . At E14.5, a rostral to caudal gradient in labeling intensity became apparent. The forebrain area and several nuclei in the brainstem, as for example, the inferior olive, the superior olive, and the pontine nuclei, still exhibited strong hybridization signals, whereas labeling intensity in other parts of the central nervous system, e.g. the spinal cord, was decreasing (Fig. 2F) . At E16.5, the developing hippocampal formation and the inferior colliculus of the mesencephalon were additionally marked by increased labeling intensity. The external granular cell layer of the cerebellum and the deep cerebellar nuclei exhibited stronger expression than the surrounding nervous tissue. Some areas of the diencephalon, as for example, the median geniculate nucleus, the nuclei of the hypothalamus, and the retina, were also marked by hybridization signals (Fig. 2G) . The cortex was no longer uniformly labeled. Strong signals were seen over the ventricular and subventricular zones and the cortical plate, whereas the intermediate zone exhibited only weak hybridization. At E18.5, signal intensities in the telencephalon and in the inferior colliculus of the mesencephalon had further increased. With the exception of the nuclei of the auditory pathway and the external granular cell layer of the cerebellum, hybridization signals were barely above background in other parts of the brain (Fig. 2H) . Sox11 was also expressed in the ganglia of the developing peripheral nervous system, albeit at relatively low levels when compared with the central nervous system. Transcripts were detected in the dorsal root ganglia (Fig. 2C) , in the craniofacial ganglia (Fig. 2D) , and in the sympathetic ganglia (data not shown).
Outside the nervous system, a variety of organs expressed Sox11 transiently at moderate levels, as exemplified for the kidney. Hybridization signals in the metanephric kidney were detected at E13.5 and were confined to the glomeruli of the cortex. At E18.5, signal intensity had declined to levels slightly above background.
Additional hybridization signals were detected in the limbs and the facial area. The limbs strongly expressed Sox11 from the earliest limb bud stages. At later stages, Sox11 was preferentially detected at the distal extremity surrounding the cartilage condensation of the digits (Fig. 2, C-E) . By E16.5, Sox11 transcripts had disappeared from the limbs.
In the facial area, Sox11 was expressed in large parts of the facial mesenchyme at E10.5 and E11.5 (Fig. 2, C and D) . At later stages, only the nasal epithelium was strongly labeled (Fig. 2, G and H) . Weaker signals were detected surrounding the optic vesicle and in the developing teeth. The whole tooth anlage exhibited hybridization with slightly higher signal intensity in the odontoblast layer (data not shown).
The general decrease in Sox11 expression during late embryogenesis continued during postnatal development, and might explain our failure to detect significant levels of Sox11 message in tissues of adult mouse and rat by Northern blot analysis. Analyzed tissues included brain, heart, skeletal muscle, testis, liver, the adrenal gland, spleen, lung, and kidney (data not shown).
To define Sox11 expression in the oligodendroglial lineage, we made use of the CG-4 cell line which has been shown to function as a reliable model system for the differentiation of oligodendrocytes from their O2-A precursors (15, 17, 20) . RNA was prepared from CG-4 cells before the onset of differentiation as well as 2 days after induction and analyzed for the presence of Sox11 transcripts in Northern blot analysis (Fig. 3A) . Transcript levels were high in undifferentiated CG-4 cells but strongly decreased during the early phase of differentiation concomitant with a reciprocal increase in myelin basic protein message, a marker for the terminal differentiation of all myelinating glia.
Similar results were also obtained in semi-quantitative PCR on cDNA from CG-4 cells. Samples were removed from each PCR after 12, 15, 18, and 21 cycles at which time amplification was still in the linear range. Amounts of cDNA present in each sample were normalized to the GAPDH-specific product obtained from each cDNA (Fig. 3B) . Undifferentiated CG-4 cells, which correspond to oligodendrocyte progenitors, expressed significant amounts of Sox11 as well as of the POU protein Brn-1. In agreement with Northern blot analysis, Sox11 expression was strongly down-regulated after differentiation of CG-4 cells as judged from the amounts of PCR products in samples from differentiated and undifferentiated CG-4 cells. The decrease of Sox11 expression was paralleled by a comparable decrease in Brn-1 expression. Reverse transcriptase-PCR analysis was also performed on cDNA samples derived from primary oligodendroglial cells and Schwann cells (Fig. 3B) . Confirming our results from CG-4 cells, Sox11 and Brn-1 were expressed in the oligodendrocyte lineage. In contrast, cDNA from Schwann cells did not contain significant amounts of Sox11 nor Brn-1.
Using reporter plasmid 3xSX luc, in which expression of luciferase is driven by a promoter consisting of a TATA box and multimerized Sox binding motifs, we next analyzed the transcriptional capacity of Sox11 by co-transfection into U138 glioblastoma cells (Fig. 4) . Sox11 proved to be a strong transcriptional activator of this luciferase reporter. We consistently observed a 30 -40-fold stimulation of this reporter by Sox11,
FIG. 2. Localization of Sox11 transcripts during embryonic development.
A-E, in situ hybridization of embryonic mice as whole mounts (A-E, from E8.5 to E13.5, lateral views) or sagittal sections (F-H, from E14.5 to E18.5). The ventral surface in lateral views and sagittal sections is to the right, the dorsal surface to the left. Abbreviations: ba, branchial arch; cb, cerebellum; cx, cortex; drg, dorsal root ganglion; fcm, facial cranial mesoderm; fl, forelimb bud; hi, hippocampus; hl, hindlimb bud; ic, inferior colliculus; io, inferior olive; ki, kidney; ne, neuroepithelium; ol, olfactory epithelium; op, optic vesicle; ot, otic vesicle; sc, spinal cord; so, somites; tel, telencephalon. whereas Sox4 led on average to a 10-fold stimulation. Notably, Sox10 failed to activate the same reporter under identical conditions (11) .
To map the region of Sox11 which is responsible for the observed transcriptional activity, we fused various parts of Sox11 to the DNA-binding domain of Gal4 (Gal4-DBD) (Fig.  5A) . Whereas co-transfection of Gal4-DBD did not lead to activation of a luciferase reporter driven by multimerized Gal4-binding sites (3xUAS luc) in U138 cells, a significant 36-fold stimulation was observed with a fusion between Gal4-DBD and the carboxyl-terminal two-thirds of Sox11 (Gal4/Sox11C1) (Fig.  5B) . Even higher induction rates were observed for a fusion of Gal4-DBD and the 122 most carboxyl-terminal amino acids of Sox11 (Gal4/Sox11C3; 199-fold induction). This contrasted sharply with the behavior of fusions between Gal4-DBD and the region amino-terminal of the HMG domain of Sox11 (Gal4/ Sox11N) or the region immediately downstream of the HMG domain (Gal4/Sox11C2), which exhibited no transactivation capacity. These results indicate that a modular transactivation domain is present within the 122 most carboxyl-terminal residues of Sox11. This transactivation domain is of considerable strength as evidenced by the fact that its activity was approximately 8.5 times higher than the activity of the transactivation domain of Tst-1/Oct6/SCIP (15, 33, 34) .
We had previously shown that Sox10 is able to synergistically activate gene expression in combination with Tst-1/Oct6/ SCIP, not, however, with Brn-1 (11). We now asked how Sox11 would behave in co-transfection experiments with POU proteins. Therefore, we carried out transient transfections in U138 glioblastoma cells using a luciferase reporter driven by a multimerized enhancer from the FGF-4 gene which is responsive to both POU and Sox proteins (3xFXO luc) (10) . As shown in Fig.  6A , co-transfection of subsaturating amounts of Sox11 led on average to a 4-fold induction of this reporter. Transfection of the same reporter with various POU domain proteins led to different stimulation rates depending on the POU protein.
Thus, Tst-1/Oct6/SCIP on average caused an 8-fold stimulation, whereas induction rates for Brn-1, Brn-2, or Brn-3 ranged between 1 (for Brn-1) and 2.5 (for Brn-2). When Sox11 was combined with the POU protein Brn-3, luciferase reporter activity remained unchanged. When Sox11 was combined with Tst-1/Oct6/SCIP, we on average observed a 15.5-fold stimulation, slightly higher than the sum of reporter gene inductions observed for either protein alone. However, when Sox11 was combined with either Brn-1 or Brn-2, we obtained a 29-and 53-fold stimulation of reporter gene activity, respectively. These stimulation rates amount to a seven times greater than multiplicative increase for the combination of Brn-1 and Sox11, and a five times greater than multiplicative increase for the combination of Brn-2 and Sox11. These results indicate that Brn-1 and Brn-2 are preferred cooperation partners for Sox11 when compared with either Tst-1/Oct6/SCIP or Brn-3. Similar to Sox11, the related Sox4 was also able to strongly stimulate the activity of Brn-1 as evident from the fact that co-transfection of expression plasmids for both proteins resulted in a 4.5 times greater than multiplicative stimulation of reporter gene activity (Fig. 6A) .
Using electrophoretic mobility shift assays, we assayed binding of Sox11 and POU proteins to the FXO enhancer region present in the reporter construct (Fig. 6B) . Brn-1, Tst-1/Oct6/ SCIP, and a Sox11-GST fusion bound with high affinity, each yielding a protein-DNA complex of characteristic mobility. When POU protein and Sox11 were simultaneously incubated with FXO, a third complex appeared that exhibited a significantly lower mobility than either the Sox11⅐FXO, Brn-1⅐FXO, or the Tst-1/Oct6/SCIP⅐FXO complex. The presence of both Sox11 and the respective POU protein within this new complex was shown by antibody perturbation experiments. Addition of a Brn-1-specific antiserum led to the disruption of both the Brn-1⅐FXO complex and the new complex, but left the Sox11⅐FXO complex intact. Similarly, addition of a Tst-1-specific antiserum led to the selective disruption of both the Tst-1/Oct6/ SCIP⅐FXO complex and the low-mobility complex. Incubation with antibodies against the GST portion of the Sox11-GST fusion protein, on the other hand, resulted in the selective disappearance of the Sox11⅐FXO complex as well as the lowmobility complex with the concomitant formation of a supershifted complex. These results conclusively show, that the lowmobility complex represents a ternary complex consisting of POU protein, Sox11, and FXO. From the fact that Tst-1/Oct6/ SCIP and Brn-1 were indistinguishable with regards to their ability for ternary complex formation, it can be concluded that ternary complex formation by itself is not sufficient to explain the different behavior of Brn-1 and Tst-1/Oct6/SCIP in cooperative function with Sox11.
When the Sox recognition site present in FXO was mutated (F-O in Fig. 6C ), binding of Sox11 to the radioactively labeled probe was abolished, whereas binding of Brn-1 remained unchanged. Disruption of the octamer site, on the other hand, selectively interfered with Brn-1 binding (FX-in Fig. 6C ). Importantly, even long exposures failed to reveal ternary complex formation on either of these mutant FXO versions, indicating that formation of a ternary complex requires both Sox11 and Brn-1 to directly bind to DNA. Mutation of both octamer and Sox recognition site abrogated complex formation completely (F-in Fig. 6C) .
To identify the regions in Brn-1 which are involved in synergistic action, we tested a set of Brn-1 mutants for their ability to cooperate with Sox11. All Brn-1 mutants were efficiently expressed and correctly localized to the nuclei of transfected cells as evident from Fig. 7B . Deletion of all amino acids carboxyl-terminal to the POU domain of Brn-1 (Brn-1⌬C) did not interfere with synergistic activation of the 3xFXO luciferase reporter in transfected U138 cells (Fig. 7A) . A Brn-1 mutant deficient in DNA-binding (Brn-1mt), on the other hand, was incapable of functionally interacting with Sox11. Deletion of the region amino-terminal to the POU domain of Brn-1 (Brn-1⌬N) likewise abolished cooperativity with Sox11.
To investigate which domains of Sox11 would be involved in the synergistic interaction, we also constructed several Sox11 mutants. Sox11⌬N corresponded to a truncated Sox11 version with residues 1-43 missing, whereas Sox11⌬C lacked all residues following the HMG domain of Sox11. All proteins were efficiently produced in transfected cells, and similar to fulllength Sox11 targeted to the nucleus as judged from Western blot analyses of nuclear extracts from transfected cells (Fig.  8B) . Despite its efficient translation, Sox11⌬C proved incapable of cooperative interaction with Brn-1, whereas removal of all amino acids preceding the HMG domain of Sox11 did not interfere with synergy (Fig. 8A) . Thus, we conclude that both the carboxyl-terminal region of Sox11 and the amino-terminal FIG. 6 . Synergistic action of Sox11 and POU proteins. A, the luciferase reporter plasmid 3xFXO luc was transfected into U138 glioblastoma cells in combination with empty CMV expression plasmid (Ϫ), pCMV/Sox11 (0.2 g/plate, Sox11), pCMV/Sox4 (0.2 g/plate), pCMV/ Tst-1 (2 g/plate, Tst-1), pCMV/Brn-1 (2 g/plate, Brn-1), pCMV/Brn-2 (2 g/plate, Brn-2), and pCMV/Brn-3.0 (2 g/plate, Brn-3) as indicated. Luciferase activities were determined in three independent experiments, each performed in duplicate. Values from transfections with luciferase reporter and empty expression plasmid were arbitrarily set to 1. Data for all other transfections are presented as fold induction above this level. B and C, radiolabeled FXO oligonucleotide with adjacent Sox-and POU-binding sites and its mutant versions FX-, F-O, and FϪϪ (sequence as shown) were incubated in electrophoretic mobility shift assays with purified recombinant Sox11-GST (Sox11), and nuclear extracts from COS cells transfected with Tst-1/Oct6/SCIP (Tst-1) or Brn-1 (Brn-1). Antibodies (Ab) directed against Tst-1 (T), Brn-1 (B), or the GST portion of Sox11-GST (Sx) were added to the reactions as indicated below the lanes. Specific complexes between a protein and FXO are marked by the name of the respective protein, while the ternary complex of Sox11, POU protein, and DNA is labeled as "TC." The supershifted complexes are marked by asterisks. The right panel in C represents a long exposure to better visualize the ternary complex.
region of Brn-1 are required in addition to the DNA binding activities of both proteins to obtain synergy.
DISCUSSION
Recent analyses have shown that the Sox family of transcriptional regulators performs functions as diverse as the expression patterns of their family members (1, 35) . Here we have identified Sox11 as one of the Sox proteins, which in addition to Sox10 and Sox4 is expressed in cells of the rat oligodendrocyte lineage. Sox11 had previously been isolated from human, mouse, chick, and Xenopus (29 -32) . Comparison of the newly identified rat sequence with its human and mouse orthologues revealed a high degree of homology especially in the aminoterminal and carboxyl-terminal parts of the protein. The middle part of the protein, corresponding to amino acids 145-267, however, exhibited substantial variability which was due to both the exchange of single amino acid residues and the insertion of amino acid stretches in the human sequence relative to rat and mouse. Nevertheless, similarity among Sox11 proteins from different species was significantly higher than similarity to Sox4 or Sox22, its closest relatives within group C of the Sox family (1, 28, 36) . Interestingly, insertion of amino acid stretches in the human relative to the mouse sequence had also been observed for Sox4 (28) . These insertions were also localized to the central portion of Sox4 which, compared with flanking regions, exhibited the lowest degree of conservation.
In addition to sharing these structural similarities, Sox11 and Sox4 exhibit a very similar expression pattern in the oligodendrocyte lineage as both proteins are expressed in the precursor cells and become down-regulated during the early stages of differentiation. This sharply contrasts with the expression profile for Sox10 in cells of the oligodendrocyte lineage (11) . Unlike Sox11 and Sox4, Sox10 is actively transcribed in both the precursor and the mature oligodendrocyte. Intriguingly, however, expression of Sox11 closely follows the expression of Brn-1 and other class III POU proteins in the oligodendrocyte lineage (15) .
Expression of Sox11 was not confined to the oligodendrocyte lineage. During embryonic development we detected transcripts of Sox11 in a variety of tissues and organs. With exception of the central nervous system, transcript abundance decreased early with ongoing development pointing to a role of Sox 11 in early determination and differentiation processes. Examples for this are seen in the developing limbs and the developing peripheral nervous system.
In the central nervous system, Sox11 is likely to be involved in two independent processes. High transcript levels were detected throughout the neuroepithelium before neural tube closure and the onset of differentiation. This expression pattern points to an important role for Sox11 in neural precursors. In later stages of neural development, similar hybridization intensities were observed in specific regions of the brain. At this point, transcripts were not confined to neural precursors only, but instead were also detected in a subset of differentiating brain areas, for example, the cortical plate or the inferior colliculus. This latter phase of expression might be indicative of a function of Sox11 in the maturation of distinct neural populations.
The spatial and temporal pattern of Sox11 expression is in some aspects reminiscent of the Brn-1 expression profile (37) . Similar to Sox11, Brn-1 is also expressed throughout the whole neuroepithelium in early stages of development, and with ongoing development, becomes restricted to certain areas of the brain which partially overlap with the Sox11 expressing regions. In common with Sox11, Brn-1 is also expressed in the developing kidney.
Several Sox proteins have been found to be only weak transcriptional activators at best (10, 38) . Thus, we previously failed to detect any transcriptional activity for rat Sox10 in transient transfections using a promoter driven by multimerized binding sites for Sox proteins (11) . Using Sox11 instead of Sox10, we now obtained a robust activation of the very same promoter, clearly indicating that rat Sox11 is a strong transcriptional activator. This conclusion was also corroborated by direct comparison with the known transcriptional activity of Sox4 (28) . The region responsible for mediating this effect localized to the extreme carboxyl-terminal part of Sox11, ex- 
FIG. 8. Sox11 protein domains involved in synergism with
Brn-1. A, the luciferase reporter plasmid 3xFXO luc was transfected into U138 glioblastoma cells in combination with empty CMV expression plasmid (Ϫ), pCMV/Brn-1 (2 g/plate, Brn-1), and CMV expression plasmids for several Sox11 versions (all 0.2 g/plate) as indicated. In addition to full-length Sox11, Sox11⌬N (lacking amino acids 1-43), and Sox11⌬C (lacking amino acids 125-395) were analyzed. Luciferase activities were determined in three independent experiments, each performed in duplicate. Values from transfections with luciferase reporter and empty expression plasmid were arbitrarily set to 1. Data for all other transfections are presented as fold induction above this level. B, comparison of expression levels between Sox11 and its mutants in nuclear extracts of transfected cells by Western blot using rabbit antiserum against Sox11. Numbers on left indicate size of molecular weight markers in kDa.
actly the same region that had been previously shown to contain the transactivation function of Sox4 (28) . The carboxylterminal regions of both proteins share substantial similarity. Both proteins contain a serine-rich domain in this region and in addition share a remarkable 82% identity over the last 34 amino acids. Thus it seems likely that one or both of these domains are involved in mediating transactivation function.
An additional feature of most Sox proteins is their ability to function cooperatively with other transcriptional regulators (10, 38) most likely due to their ability to bend DNA (39 -41) and thereby organize local chromatin structure (35) . Cooperativity between Sox and POU proteins has been observed in two cases: in embryonic stem cells between Sox2 and Oct-3/4 (10), and in glial cells between Sox10 and Tst-1/Oct6/SCIP (11) . This report now shows that Sox11 is also capable of synergistic interaction with POU proteins. Interestingly, Sox11 (and similarly Sox4) chooses Brn-1 and Brn-2 as its preferred partners. Tst-1/Oct6/SCIP, on the other hand, which is the preferred partner for Sox10 (11) , did not synergistically function with Sox11. Neither did Brn-3.0. Taken together with our previous observation that Brn-1 did not function with Sox10, this leads us to postulate that there exists a specific combinatorial code in which members of the POU and Sox families influence each others activity. Whereas POU and Sox proteins might synergistically enhance each other's activity in certain combinations, they might be unresponsive to each other's presence in other combinations or even interfere with each other's function. Thus, gene expression in a given cell might be dependent on a specific combination of Sox and POU protein.
Our results also show that Sox11 and Sox4 are coordinately expressed in the oligodendrocyte lineage and behave similar in a number of functional tests. Thus, Sox11 and Sox4 might perform overlapping, if not identical functions in the oligodendrocyte lineage. The resulting redundancy might very well explain the absence of an obvious defect in oligodendrocytes from Sox4-deficient mice (27) .
The presence of Sox11 and Sox4 in the oligodendrocyte lineage might also be important for achieving functional redundancy on a different level. Schwann cells only express a single class III POU protein, namely Tst-1/Oct6/SCIP (12) which efficiently cooperates with Sox10 (11) . Oligodendrocytes, on the other hand, express Brn-1 and Brn-2 in addition to Tst-1/Oct6/ SCIP. Previous analysis has shown that Brn-1 is unable to cooperate with Sox10 and cannot replace Tst-1/Oct6/SCIP in this function (11) . Redundancy of POU proteins in the oligodendrocyte lineage can, however, be restored by supplying additional Sox proteins which can cooperate with Brn-1. Matching the multiplicity of POU proteins with a similar multiplicity of Sox proteins in cells of the oligodendrocyte lineage might be paramount to ensuring a maximum of functional redundancy.
